Navigation Links
Scientists at CSHL uncover new RNA processing mechanism and a new class of small RNAs

A very small fraction of our genetic material--about 2%-- performs the crucial task scientists once thought was the sole purpose of the genome: to serve as a blueprint for the production of proteins, the molecules that make cells work and sustain life. This 2% of human DNA is converted into intermediary molecules called RNAs, which in turn carry instructions within cells for protein manufacture.

And what of the other 98% of the genome? It has been assumed by many to be genetic junk, a massive accumulation of "code" that evolution has rendered superfluous. Now, however, scientists are discovering that the vast bulk of the DNA in our genomes, while it does not "code" for the specific RNA molecules that serve as templates for protein synthesis, do nevertheless perform various kinds of work. But what types of work, involving what kinds of cellular mechanisms? Given its relative abundance, non-coding DNA and RNA present inviting targets for experimentation.

For years, a laboratory at Cold Spring Harbor Laboratory (CSHL) led by Professor David L. Spector, Ph.D., has studied events within the cell nucleus, where the genetic material is contained. In the November 26th issue of Cell, Spector and a team led by graduate student Jeremy Wilusz report their discovery of a previously unknown mechanism in the nucleus that processes non-coding RNA molecules.

Spector and colleagues discovered the mechanism while examining a non-coding RNA molecule called MALAT1. Resident in the cell nucleus, MALAT1 was observed to split into two parts, one long and one very shortthe latter qualifying as a species of RNA that scientists call small RNAs. The small RNA segment was observed to migrate out of the nucleus into the cell's aqueous cytoplasm. The longer remnant of MALAT1 remained in the nucleus, accumulating in distinct zones called nuclear speckles.

Although it is not yet clear what these processed parts of the original MALAT1 molecule do, their disparate destinations in the cell suggest that they likely serve different functions. And that, Dr. Spector says, is intriguing in part because MALAT1 is known to be a good marker of cancer progression: it is found at abnormally high levels in the nuclei of cancer cells with a propensity to become metastatic.

One new RNA molecule; more to come?

The discovery of the cytoplasmic small RNA fragment of the non-coding MALAT1 molecule, which the CSHL team calls mascRNA, (MALAT1-associated small cytoplasmic RNA) is "just the tip of the iceberg of a whole new class of small RNAs," according to Spector.

This new kid on the small RNA block was found by Spector's lab to be present in most cell types, and is highly conserved, or retained by evolution across many species. In the growing menagerie of small RNA molecules, mascRNA is processed and assumes a physical shape much like that of transfer RNA, or tRNA, an RNA string that folds into a cloverleaf-shaped structure.

tRNA molecules are part of the construction crew that builds proteins; they carry amino acids--the building blocks of proteins-- to protein chains as they are being assembled. But the CSHL team's results suggest that mascRNA, which is smaller than most tRNAs, does not likely perform this function. Yet mascRNA's location in the cell's cytoplasm and its pathway of biogenesis does hint at a possible function. Spector suspects it may act as a "sponge" for proteins, preventing them from reaching their natural destinations within the cell. Another possibility is that mascRNA simply serves to alert the cell that the long non-coding RNA fragment that it originally split off from-- MALAT1--is "available" in the nucleus for other cellular duties.

Broader implications: a new RNA processing mechanism

Researchers now think that at least 40% of long, non-coding RNAs--a considerable chunk of RNA segments that float around the nucleus--may be processed to generate smaller RNA pieces such as mascRNA, and also other classes of RNA. While the hunt has begun for other tRNA-like small RNAs and their precursor RNAs like MALAT1, the new results from Spector's lab provide a first look at how these bits are produced.

In the case of coding RNAs, once their sequence has been "read" off a DNA template, a molecular complex snips off the tail end of this new piece and tacks on a signal at its end that protects the new molecule from degradation and marks it for export out of the nucleus. In non-coding MALAT1, however, the CSHL team found the protective signal was already embedded within the molecule, just ahead of the portion that later detached to form mascRNA. The molecular complex responsible for cleaving MALAT1 therefore knew precisely where to make its cut--right after the embedded signal--rather than at MALAT1's tail end. In this way, MALAT1 is effectively preconfigured to liberate the mascRNA fragment.

The mechanism that retains the long MALAT1 molecule within the nucleus while expelling the mascRNA fragment into the cytoplasm is still elusive. "The answer will come when we identify more and more RNAs that are built like the MALAT1 precursor and are processed to give rise to different types of RNAs," says Spector.

In the meantime, his lab's current work provides reason to believe that the community of non-coding RNAs has many more surprises to reveal. To the extent that its members can be shown to perform specific functions, it will seem increasingly inapt to consider non-coding RNAs the byproducts of "junk DNA."


Contact: Hema Bashyam
Cold Spring Harbor Laboratory

Related medicine news :

1. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
2. Scientists Probe Sepsis Deadly Secrets
3. Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
4. Scientists Develop Natural Protection for Stored Foods
5. Scientists detect presence of marburg virus in african fruit bats
6. Scientists Spot Brains Free Will Center
7. Scientists ID Likely Culprit in Popcorn Lung
8. Scientists explain how insulin secreting cells maintain their glucose sensitivity
9. Scripps Research scientists shed new light on how antibodies fight HIV
10. Scientists, physicians present latest findings in personalized cancer treatment and prevention
11. Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds
Post Your Comments:
(Date:11/27/2015)... ... 27, 2015 , ... Keeping in mind challenges faced by ... wellness consultation, has collaborated with a leading web-based marketplace for extra-curricular activities for ... parents and bring advice from parenting experts within their reach. As a part ...
(Date:11/27/2015)... ... November 27, 2015 , ... Avid collector, Andrew Hawley from Vintage Rock ... concert posters. This is one of Joplin's most famous and beautiful concert posters. The ... of Michigan in Ann Arbor. The According to Hawley, "It is hard to believe ...
(Date:11/26/2015)... and Cambridge, ON (PRWEB) , ... November 26, ... ... the availability of a real-time eReferral system for diagnostic imaging in the Waterloo ... X-rays, mammography, BMD and Nuclear Medicine tests directly from their electronic medical record ...
(Date:11/26/2015)... ... ... PRMA Plastic Surgery is updating their record books yet again with an ... breast reconstruction surgery! , “What an accomplishment for the PRMA team, says Dr. ... an honor to have served all of these women.” , PRMA is one of ...
(Date:11/26/2015)... ... November 26, 2015 , ... Indosoft Inc., developer and distributor ... application server to improve system efficiency and reliability. , The new Q-Suite 6 platform ... standards, the system avoids locking itself into a specific piece of software for many ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Drug Monitoring (TDM) Market: Supplier Shares, ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
(Date:11/26/2015)... 26, 2015 Research and Markets ( ... "2016 Future Horizons and Growth Strategies in ... Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities" ... --> --> This new ... Italian therapeutic drug monitoring market, including emerging tests, ...
(Date:11/25/2015)... , Nov. 25, 2015 ... addition of the "Global Brain Monitoring ... offering. --> ) has ... Brain Monitoring Devices Market 2015-2019" report ... and Markets ( ) has announced ...
Breaking Medicine Technology: